MARSHALL WACE, LLP - BIOPLUS ACQUISITION CORP ownership

Back to all holdings Add to watchlist

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 68 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q4 2022$5,164,159
+2.3%
502,3500.0%0.01%
+9.1%
Q3 2022$5,049,000
+31.3%
502,350
+31.4%
0.01%
+37.5%
Q2 2022$3,844,000
+2.3%
382,350
+0.5%
0.01%
+14.3%
Q1 2022$3,758,000–380,300–0.01%–
 Download
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 718,701$7,790,6470.97%
BERKLEY W R CORP 1,119,638$12,125,6800.79%
First Trust Capital Management L.P. 1,106,378$11,993,0270.66%
COWEN AND COMPANY, LLC 679,393$7,364,5520.52%
Westchester Capital Management, LLC 1,390,000$15,053,7010.44%
METEORA CAPITAL, LLC 235,256$2,550,1520.44%
BCK CAPITAL MANAGEMENT LP 74,268$805,0580.41%
Exos TFP Holdings LLC 60,000$650,4000.35%
PERISCOPE CAPITAL INC. 250,000$2,709,9750.31%
FIR TREE CAPITAL MANAGEMENT LP 230,111$2,492,1020.26%
View complete list of BIOPLUS ACQUISITION CORP shareholders